Key Team Additions Drive Enhancements to the Milacron European Injection Machine Sales and Service Structure
(CINCINNATI, OHIO – May 31, 2016) – Milacron Holdings Corp. (NYSE: MCRN), a leading industrial technology company serving the plastics processing industry announced a revamped customer centric sales structure for its European Injection Machine sales team. The changes are designed to improve the delivery of customer support for sales, service, and simplifying the way Milacron interacts with its customers.
Denis Poelman, Managing Director, Milacron Injection Europe stated, “Milacron’s enhancement of our European Sales and Service structure will improve efficiency and reduce complexity. This new organizational structure will enable Milacron to better serve our valued customers”.
The new sales structure will operate from five main sales offices: Malterdingen, Germany to serve German speaking markets, Magenta, Italy to serve Italian speaking markets, Lyon, France to serve French speaking markets, Barcelona, Spain to serve Spanish and Portuguese speaking markets and Vsetin, Czech Republic to serve Eastern European, Nordic and English speaking markets. The new structure will see improvements in language capabilities, with the ability to serve customers in sixteen languages, ensuring customers are served in their mother tongue and in closer geographic proximity.
Milacron will also be adding local High Impact Technical (HIT) Centers in Germany, Spain, Czech Republic, Italy, France, UK , Denmark and Sweden to allow customers to experience Milacron’s wide product offerings in person. Milacron HIT Centers feature a technology showroom including cells that showcase the entire Milacron product portfolio from machines to hot runners. The centers also have training areas, warehousing capabilities, with space for spare parts inventory plus on-site field service technicians. The objective is to ensure Milacron is closer to our customers, increasing service, and support response times.
The key additions and enhancements serve to strengthen Milacron’s sales and service operations and reinforce Milacron’s commitment to the key European plastics market. This investment confirms Milacron’s commitment to support its customers locally in key markets.
Highlights of the new structure include:
- 5 key sales headquarters (Germany, Italy, France, Spain, Czech Republic), previously everything was centralized in Germany.
- HIT Centers in Germany, Spain, Czech Republic, Italy, France, UK, Denmark and Sweden.
- Sales staff covering 16 distinct languages.
- In addition to our industry leading sales staff, we will be further expanding our direct sales resource structure in Eastern Europe, Poland, Czech Republic and Hungry.
- Solution focused sales organization will allow for improved customer support.
“The move to optimize our European Injection Sales and Service structure is a direct result of feedback from our European customers. Our primary goal is to serve our customers throughout the entire product lifecycle in a manner that works best for them,” said Shawn Reilley, Vice-President and General Manager, Milacron Injection. Reilley added “The realignment of the Sales and Service teams will allow Milacron to be more responsive, agile and better positioned to work with and serve our customers”.
Milacron continues to push the boundaries of possibilities in plastics with breakthrough products from leading brands including Milacron, Mold-Masters, DME, Ferromatik, Uniloy and CIMCOOL.
Download High Resolution Images: https://www.dropbox.com/sh/2csx8t0y4hi9teh/AAC_WgZhHD9lXpEuv__zc_5Ma?dl=0
Milacron is a global leader in the manufacture, distribution and service of highly engineered and customized systems within the plastic technology and processing industry. Milacron is the only global company with a full-line product portfolio that includes hot runner systems, injection molding, blow molding and extrusion equipment plus a wide market range of advanced fluid technologies. Visit Milacron at milacron.com
For more information, contact:
Michael Ellis, Milacron
905-877-0185 ext. 354
Director of Investor Relations